Delivery Order SPE2DB20D3505-SPE2DB25FV1B8
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The contract is a firm-fixed price arrangement with a ceiling value of $7,987.56 and a period of performance through August 13, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- The Defense Logistics Agency Troop Support Medical awarded a $224.76 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg lamotrigine ER tablets. As the prime contractor, Amerisourcebergen Drug will deliver 30 tablets to a location in Conshohocken, Pennsylvania under a firm fixed price contract concluding on August 7, 2023. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen Corporation Division. No subcontractors or set...
- This is a $1,065.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of 200 mg Lamotrigine ER tablets, which are used to treat certain types of seizures. The contract has a completion date of June 24, 2025 and is not set aside for any small business category. AmerisourceBergen Drug Corp is the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a $779 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 lamotrigine ER 50 mg tablets. The order was placed under an existing prime vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 24, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this delivery order supports DLA's mission to provide critical medical materiel to...
- This federal contract award, valued at $1,280.53, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lamotrigine ER 300 mg tablets for a period ending on September 19, 2024. This is a firm fixed-price delivery order contract, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lamotrigine ODT 100 mg tablets. The contract has a potential value of $2,958.34 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This delivery order is part of a larger indefinite delivery contract (IDC)...
- The federal contract award is for the supply of the medication Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA). The $4,284.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide $3,618.84 worth of lamotrigine ER 50 mg tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 7, 2023. No set-aside designation was applied to this...